NJ
Nehal Jaydeep Gadhavi
About Nehal Jaydeep Gadhavi
Data last updated:
Nehal Jaydeep Gadhavi is a Director at Namostute Superspeciality Hospitals Private Limited (since 2022), Director at Namostute Healthcare Private Limited (since 2021) and Director at Namostute Icu And Critical Care Private Limited (since 2022). The companies operate in Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹20.36 Cr; the largest is Namostute Superspeciality Hospitals Private Limited at ₹9.55 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Jul 2022 | 2021 | ₹9.55 Cr (FY 2025) | Active | |
| Director | 19 Apr 2021 | 2021 | ₹6.21 Cr (FY 2025) | Active | |
| Director | 16 Feb 2022 | 2021 | ₹4.60 Cr (FY 2024) | Active |
Board colleagues of Nehal Jaydeep Gadhavi
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nehal Jaydeep Gadhavi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nehal Jaydeep Gadhavi
Nehal Jaydeep Gadhavi currently holds 3 directorships: Namostute Superspeciality Hospitals Private Limited (Director, since 01 Jul 2022, revenue ₹9.55 Cr (FY 2025)); Namostute Healthcare Private Limited (Director, since 19 Apr 2021, revenue ₹6.21 Cr (FY 2025)); Namostute Icu And Critical Care Private Limited (Director, since 16 Feb 2022, revenue ₹4.60 Cr (FY 2024)).
Nehal Jaydeep Gadhavi was first appointed on 19 Apr 2021 as Director at Namostute Healthcare Private Limited. The most recent appointment on record is 01 Jul 2022 at Namostute Superspeciality Hospitals Private Limited.
The 3 current companies of Nehal Jaydeep Gadhavi that report revenue have a combined latest revenue of ₹20.36 Cr: Namostute Superspeciality Hospitals Private Limited ₹9.55 Cr (FY 2025); Namostute Healthcare Private Limited ₹6.21 Cr (FY 2025); Namostute Icu And Critical Care Private Limited ₹4.60 Cr (FY 2024).
The current boards of Nehal Jaydeep Gadhavi's companies include Jignesh Pravinbhai Rajvir (Namostute Superspeciality Hospitals Private Limited), Kumar Rajeshbhai Mehta (Namostute Superspeciality Hospitals Private Limited), Ramanbhai Gamabhai Patel (Namostute Superspeciality Hospitals Private Limited), Jaykumar Rajeshkumar Sanghavi (Namostute Healthcare Private Limited), Dinkar Goswami (Namostute Icu And Critical Care Private Limited), Jaykumar Manharlal Patel (Namostute Icu And Critical Care Private Limited), among others.